Your browser doesn't support javascript.
loading
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry.
Friebel, Tara M; Andrulis, Irene L; Balmaña, Judith; Blanco, Amie M; Couch, Fergus J; Daly, Mary B; Domchek, Susan M; Easton, Douglas F; Foulkes, William D; Ganz, Patricia A; Garber, Judy; Glendon, Gord; Greene, Mark H; Hulick, Peter J; Isaacs, Claudine; Jankowitz, Rachel C; Karlan, Beth Y; Kirk, Judy; Kwong, Ava; Lee, Annette; Lesueur, Fabienne; Lu, Karen H; Nathanson, Katherine L; Neuhausen, Susan L; Offit, Kenneth; Palmero, Edenir I; Sharma, Priyanka; Tischkowitz, Marc; Toland, Amanda E; Tung, Nadine; van Rensburg, Elizabeth J; Vega, Ana; Weitzel, Jeffrey N; Collaborators, Gemo Study; Hoskins, Kent F; Maga, Tara; Parsons, Michael T; McGuffog, Lesley; Antoniou, Antonis C; Chenevix-Trench, Georgia; Huo, Dezheng; Olopade, Olufunmilayo I; Rebbeck, Timothy R.
Afiliación
  • Friebel TM; Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Andrulis IL; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Balmaña J; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Blanco AM; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Couch FJ; High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Daly MB; Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, California.
  • Domchek SM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Easton DF; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Foulkes WD; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Ganz PA; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
  • Garber J; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
  • Glendon G; Departments of Human Genetics and Oncology, Program in Cancer Genetics, McGill University, Montréal, Quebec, Canada.
  • Greene MH; Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Centre, Schools of Medicine and Public Health, UCLA, Los Angeles, California.
  • Hulick PJ; Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Isaacs C; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Jankowitz RC; Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch, National Cancer Institute, Bethesda, Maryland.
  • Karlan BY; Center for Medical Genetics, NorthShore University HealthSystem, Evanston, Illinois.
  • Kirk J; The University of Chicago Pritzker School of Medicine, Chicago, Illinois.
  • Kwong A; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
  • Lee A; Division of Hematology/Oncology, Department of Medicine, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Lesueur F; Cedars-Sinai Medical Center, Womens Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California.
  • Lu KH; Familial Cancer Service, Weatmead Hospital, Wentworthville, New South Wales, Australia.
  • Nathanson KL; Cancer Genetics Centre, Hong Kong Hereditary Breast Cancer Family Registry, Happy Valley, Hong Kong, China.
  • Neuhausen SL; Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong, China.
  • Offit K; Department of Surgery, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong, China.
  • Palmero EI; The Feinstein Institute for Medical Research, Manhasset, New York.
  • Sharma P; Genetic Epidemiology of Cancer team, Inserm, Paris, France.
  • Tischkowitz M; Service de Génétique, Institut Curie, Paris, France.
  • Toland AE; Institut Curie, Paris, France.
  • Tung N; Mines ParisTech, Fontainebleau, France.
  • van Rensburg EJ; Department of Gynecologic Oncology and Clinical Cancer Genetics Program, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vega A; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Weitzel JN; Department of Population Sciences, Beckman Research Institute of City of Hop, Duarte, California.
  • Collaborators GS; Department of Cancer Biology and Genetics, Clinical Genetics Research Lab, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Hoskins KF; Department of Medicine, Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Maga T; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil.
  • Parsons MT; Barretos School of Health Sciences, Dr. Paulo Prata-FACISB, São Paulo, Brazil.
  • McGuffog L; Division of Oncology, Department of Internal Medicine, University of Kansas Medical Center, Westwood, Kansas.
  • Antoniou AC; Departments of Human Genetics and Oncology, Program in Cancer Genetics, McGill University, Montréal, Quebec, Canada.
  • Chenevix-Trench G; Department of Medical Genetics, Addenbrookes Treatment Centre, Addenbrookes Hosptital, University of Cambridge, Cambridge, UK.
  • Huo D; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, Ohio.
  • Olopade OI; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Rebbeck TR; Department of Genetics, University of Pretoria, Arcadia, South Africa.
Hum Mutat ; 40(10): 1781-1796, 2019 10.
Article en En | MEDLINE | ID: mdl-31112363
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Variación Genética / Proteína BRCA1 / Predisposición Genética a la Enfermedad / Proteína BRCA2 / Población Negra Tipo de estudio: Prognostic_studies / Screening_studies Límite: Female / Humans Idioma: En Revista: Hum Mutat Asunto de la revista: GENETICA MEDICA Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Variación Genética / Proteína BRCA1 / Predisposición Genética a la Enfermedad / Proteína BRCA2 / Población Negra Tipo de estudio: Prognostic_studies / Screening_studies Límite: Female / Humans Idioma: En Revista: Hum Mutat Asunto de la revista: GENETICA MEDICA Año: 2019 Tipo del documento: Article